Published in N Engl J Med on January 25, 1996
Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet (2006) 4.23
Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol (1998) 3.15
PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol (1997) 2.59
Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol (1998) 2.44
An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 2.32
Ehrlichia canis-like agent isolated from a man in Venezuela: antigenic and genetic characterization. J Clin Microbiol (1996) 2.29
Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J Clin Microbiol (1999) 2.14
Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J Clin Microbiol (1997) 1.98
Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect Immun (1998) 1.92
Sequence analysis of the msp4 gene of Anaplasma phagocytophilum strains. J Clin Microbiol (2005) 1.84
Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J Clin Microbiol (1996) 1.79
Prevalence of granulocytic Ehrlichia infection among white-tailed deer in Wisconsin. J Clin Microbiol (1997) 1.78
Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family. Infect Immun (1998) 1.72
Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect Immun (2003) 1.70
New Ehrlichia species closely related to Ehrlichia chaffeensis isolated from Ixodes ovatus ticks in Japan. J Clin Microbiol (2000) 1.64
Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol (1998) 1.64
Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum. J Clin Microbiol (2003) 1.62
Transformation of Anaplasma phagocytophilum. BMC Biotechnol (2006) 1.60
Serologic testing for human granulocytic ehrlichiosis at a national referral center. J Clin Microbiol (1999) 1.58
Anaplasma phagocytophilum--a widespread multi-host pathogen with highly adaptive strategies. Front Cell Infect Microbiol (2013) 1.57
Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest (1997) 1.56
Citrate synthase gene sequence: a new tool for phylogenetic analysis and identification of Ehrlichia. J Clin Microbiol (2001) 1.55
Silencing of host cell CYBB gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect Immun (2009) 1.51
Molecular cloning and sequencing of three granulocytic Ehrlichia genes encoding high-molecular-weight immunoreactive proteins. Infect Immun (1998) 1.50
Whole genome transcription profiling of Anaplasma phagocytophilum in human and tick host cells by tiling array analysis. BMC Genomics (2008) 1.45
Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J Clin Microbiol (1999) 1.45
Identification of Ehrlichia chaffeensis by nested PCR in ticks from Southern China. J Clin Microbiol (2000) 1.44
Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin Microbiol Rev (2011) 1.44
Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am J Pathol (2001) 1.42
Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State. J Clin Microbiol (1997) 1.41
Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J Clin Microbiol (1997) 1.40
Structure of the expression site reveals global diversity in MSP2 (P44) variants in Anaplasma phagocytophilum. Infect Immun (2006) 1.40
A 16S rRNA-based PCR assay for detection and identification of granulocytic Ehrlichia species in dogs, horses, and cattle. J Clin Microbiol (1996) 1.37
Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect Immun (2001) 1.36
Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Expert Rev Anti Infect Ther (2009) 1.33
Serology of culture-confirmed cases of human granulocytic ehrlichiosis. J Clin Microbiol (2000) 1.32
Serologic evidence of infection with Ehrlichia spp. in wild rodents (Muridae: Sigmodontinae) in the United States. J Clin Microbiol (1998) 1.32
The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment. J Clin Invest (1998) 1.31
Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect Immun (2003) 1.29
Serologic and molecular detection of granulocytic ehrlichiosis in Rhode Island. J Clin Microbiol (1997) 1.26
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun (2001) 1.26
Dusky-footed wood rats (Neotoma fuscipes) as reservoirs of granulocytic Ehrlichiae (Rickettsiales: Ehrlichieae) in northern California. J Clin Microbiol (1999) 1.25
Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. J Clin Invest (1999) 1.24
Isolation and propagation of the Ap-Variant 1 strain of Anaplasma phagocytophilum in a tick cell line. J Clin Microbiol (2007) 1.24
Anaplasma phagocytophilum from Rodents and Sheep, China. Emerg Infect Dis (2010) 1.22
Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients. J Clin Microbiol (2002) 1.22
An Ehrlichia strain from a llama (Lama glama) and Llama-associated ticks (Ixodes pacificus). J Clin Microbiol (1997) 1.21
Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun (2003) 1.20
Global proteomic analysis of two tick-borne emerging zoonotic agents: anaplasma phagocytophilum and ehrlichia chaffeensis. Front Microbiol (2011) 1.18
Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob Agents Chemother (1997) 1.17
Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates. J Clin Microbiol (1998) 1.17
Characterization of an immunoreactive protein from the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 1.17
Simultaneous detection of Anaplasma marginale and a new Ehrlichia species closely related to Ehrlichia chaffeensis by sequence analyses of 16S ribosomal DNA in Boophilus microplus ticks from Tibet. J Clin Microbiol (2002) 1.16
Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae. J Clin Microbiol (2000) 1.16
Experimental transmission of Ehrlichia equi to horses through naturally infected ticks (Ixodes pacificus) from Northern California. J Clin Microbiol (1998) 1.14
Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics. J Bacteriol (2007) 1.13
Reduction of tick infections with Anaplasma marginale and A. phagocytophilum by targeting the tick protective antigen subolesin. Parasitol Res (2006) 1.13
Neutrophil NADPH oxidase is reduced at the Anaplasma phagocytophilum phagosome. Infect Immun (2004) 1.12
Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes. J Clin Microbiol (1997) 1.12
Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteins. J Clin Microbiol (2001) 1.10
Serologic evidence of a natural infection of white-tailed deer with the agent of human granulocytic ehrlichiosis in Wisconsin and Maryland. Clin Diagn Lab Immunol (1998) 1.09
Anaplasma phagocytophilum reduces neutrophil apoptosis in vivo. Infect Immun (2003) 1.09
Detection of antibodies to Anaplasma phagocytophilum and Ehrlichia chaffeensis antigens in sera of Korean patients by western immunoblotting and indirect immunofluorescence assays. Clin Diagn Lab Immunol (2003) 1.09
Porin activity of Anaplasma phagocytophilum outer membrane fraction and purified P44. J Bacteriol (2006) 1.08
Human granulocytic anaplasmosis. Infect Dis Clin North Am (2015) 1.08
Coinfection with three Ehrlichia species in dogs from Thailand and Venezuela with emphasis on consideration of 16S ribosomal DNA secondary structure. J Clin Microbiol (2001) 1.07
Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. J Clin Microbiol (1999) 1.04
Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum. Vet Parasitol (2009) 1.04
Current and past strategies for bacterial culture in clinical microbiology. Clin Microbiol Rev (2015) 1.02
Anaplasma phagocytophilum p44 mRNA expression is differentially regulated in mammalian and tick host cells: involvement of the DNA binding protein ApxR. J Bacteriol (2007) 1.00
Analysis of involvement of the RecF pathway in p44 recombination in Anaplasma phagocytophilum and in Escherichia coli by using a plasmid carrying the p44 expression and p44 donor loci. Infect Immun (2006) 1.00
Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection. Infect Immun (2005) 0.99
Transovarial transmission of Francisella-like endosymbionts and Anaplasma phagocytophilum variants in Dermacentor albipictus (Acari: Ixodidae). J Med Entomol (2009) 0.99
Antimicrobial susceptibility of Ehrlichia phagocytophila. Antimicrob Agents Chemother (2001) 0.99
Experimental inoculation with human granulocytic Ehrlichia agent derived from high- and low-passage cell culture in horses. J Clin Microbiol (2000) 0.98
Proteomic analysis of Anaplasma phagocytophilum during infection of human myeloid cells identifies a protein that is pronouncedly upregulated on the infectious dense-cored cell. Infect Immun (2011) 0.97
Outcomes of treated human granulocytic ehrlichiosis cases. Emerg Infect Dis (2002) 0.97
Isolation of an Anaplasma sp. organism from white-tailed deer by tick cell culture. J Clin Microbiol (2003) 0.96
Ixodes ovatus Ehrlichia exhibits unique ultrastructural characteristics in mammalian endothelial and tick-derived cells. Ann N Y Acad Sci (2009) 0.95
Defective phagocytosis in Anaplasma phagocytophilum-infected neutrophils. Infect Immun (2005) 0.95
Proteomic identification of a novel Anaplasma phagocytophilum DNA binding protein that regulates a putative transcription factor. J Bacteriol (2007) 0.95
Coinfection with Anaplasma phagocytophilum alters Borrelia burgdorferi population distribution in C3H/HeN mice. Infect Immun (2005) 0.95
Anaplasma phagocytophilum has a functional msp2 gene that is distinct from p44. Infect Immun (2004) 0.95
Opening the black box of Anaplasma phagocytophilum diversity: current situation and future perspectives. Front Cell Infect Microbiol (2015) 0.94
Differences in the transmissibility of two Anaplasma phagocytophilum strains by the North American tick vector species, Ixodes pacificus and Ixodes scapularis (Acari: Ixodidae). Exp Appl Acarol (2006) 0.93
Evaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by real-time PCR. Antimicrob Agents Chemother (2004) 0.92
Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions. J Clin Microbiol (2000) 0.92
Predominance of Ehrlichia ewingii in Missouri dogs. J Clin Microbiol (2003) 0.90
Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother (2003) 0.90
In situ detection of Anaplasma spp. by DNA target-primed rolling-circle amplification of a padlock probe and intracellular colocalization with immunofluorescently labeled host cell von Willebrand factor. J Clin Microbiol (2008) 0.89
In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis. J Clin Pathol (2004) 0.89
Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase. Infect Immun (2000) 0.87
Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data. Am J Trop Med Hyg (2015) 0.87
Molecular typing of the etiologic agent of human granulocytic ehrlichiosis. J Clin Microbiol (2001) 0.86
Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis. Infect Immun (1998) 0.85
Traditional and molecular techniques for the study of emerging bacterial diseases: one laboratory's perspective. Emerg Infect Dis (2002) 0.85
Subversion of NPC1 pathway of cholesterol transport by Anaplasma phagocytophilum. Cell Microbiol (2012) 0.85
Temporal and spatial variation in Anaplasma phagocytophilum infection in Swedish moose (Alces alces). Epidemiol Infect (2013) 0.85
Anaplasma phagocytophilum strains from voles and shrews exhibit specific ankA gene sequences. BMC Vet Res (2013) 0.84
Cloning and characterization of an Ehrlichia canis gene encoding a protein localized to the morula membrane. Infect Immun (2003) 0.84
The sequence of the human genome. Science (2001) 101.55
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Race, gender, and partnership in the patient-physician relationship. JAMA (1999) 13.80
Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol (1994) 9.97
Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array. Nat Biotechnol (1999) 9.35
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA (1994) 6.55
Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis (1995) 5.26
A family of human cdc2-related protein kinases. EMBO J (1992) 4.96
Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA (1996) 4.88
Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia. J Clin Microbiol (1995) 4.54
Identification of a novel rickettsial infection in a patient diagnosed with murine typhus. J Clin Microbiol (1994) 4.06
Emergence of the ehrlichioses as human health problems. Emerg Infect Dis (1996) 3.89
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J (2000) 3.81
Endosymbionts of ticks and their relationship to Wolbachia spp. and tick-borne pathogens of humans and animals. Appl Environ Microbiol (1997) 3.65
Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med (1996) 3.41
Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol (1997) 3.28
Ropivacaine-induced seizure after extradural anaesthesia. Br J Anaesth (1998) 3.24
Nested polymerase chain reaction for detection of Ehrlichia equi genomic DNA in horses and ticks (Ixodes pacificus). Vet Parasitol (1996) 2.51
Induction of the LIM homeobox gene Lmx1 by WNT7a establishes dorsoventral pattern in the vertebrate limb. Cell (1995) 2.38
Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to Ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J Clin Microbiol (1995) 2.38
Establishment, maintenance and description of cell lines from the tick Ixodes scapularis. J Parasitol (1994) 2.36
Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis. Am J Clin Pathol (1997) 2.35
Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol (1995) 2.32
Interexaminer reliability of eight evaluative dimensions of lumbar segmental abnormality: Part II. J Manipulative Physiol Ther (1993) 2.32
Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J Infect Dis (1995) 2.31
Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J Infect Dis (1997) 2.31
Human granulocytic ehrlichiosis in Europe. Lancet (1995) 2.25
Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs. J Clin Microbiol (1996) 2.14
Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J Clin Microbiol (1999) 2.14
Identification of the antigenic constituents of Ehrlichia chaffeensis. Am J Trop Med Hyg (1994) 2.13
Clinical versus mechanical prediction: a meta-analysis. Psychol Assess (2000) 2.12
PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol (1998) 2.12
Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer. Mol Endocrinol (1991) 2.03
ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect Immun (2000) 2.02
Equine ehrlichiosis in northern California: 49 cases (1968-1981). J Am Vet Med Assoc (1987) 2.01
Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology (2008) 2.00
Human granulocytic ehrlichiosis in Connecticut: report of a fatal case. Clin Infect Dis (1995) 1.97
Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci U S A (1996) 1.97
Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant (2011) 1.96
Exposure to deer blood may be a cause of human granulocytic ehrlichiosis. Clin Infect Dis (1996) 1.94
The burden of inherited leukodystrophies in children. Neurology (2010) 1.89
Ixodes pacificus (Acari: Ixodidae) as a vector of Ehrlichia equi (Rickettsiales: Ehrlichieae). J Med Entomol (1996) 1.89
Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains. Clin Infect Dis (1997) 1.85
Maternal age and screening for gestational diabetes: a population-based study. Obstet Gynecol (1989) 1.84
Serological evidence of human granulocytic ehrlichiosis in Norway. Eur J Clin Microbiol Infect Dis (1996) 1.84
Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA (1996) 1.82
Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J Clin Microbiol (1996) 1.79
Antigenic characterization of ehrlichiae: protein immunoblotting of Ehrlichia canis, Ehrlichia sennetsu, and Ehrlichia risticii. J Clin Microbiol (1992) 1.74
Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med (1995) 1.74
Human granulocytic ehrlichiosis. Clin Infect Dis (2000) 1.72
Natural infection of small mammal species in Minnesota with the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 1.70
Formulation of medium for tick cell culture. Exp Appl Acarol (1989) 1.70
Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent). J Clin Microbiol (1995) 1.70
Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect Immun (2003) 1.70
Identification of Ehrlichia in human tissue. N Engl J Med (1991) 1.69
Field replication of classwide peer tutoring. J Appl Behav Anal (1987) 1.66
A multidimensional approach to the structure of personality impressions. J Pers Soc Psychol (1968) 1.66
Biliopancreatic diversion for obesity at eighteen years. Surgery (1996) 1.66
Colony formation and morphology in Borrelia burgdorferi. J Clin Microbiol (1987) 1.66
Establishment of the tick (Acari:Ixodidae)-borne cattle pathogen Anaplasma marginale (Rickettsiales:Anaplasmataceae) in tick cell culture. J Med Entomol (1996) 1.65
Spinal manipulation vs. amitriptyline for the treatment of chronic tension-type headaches: a randomized clinical trial. J Manipulative Physiol Ther (1995) 1.65
Equine granulocytic ehrlichiosis in Connecticut caused by an agent resembling the human granulocytotropic ehrlichia. J Clin Microbiol (1996) 1.64
Discrete cis-active genomic sequences dictate the pituitary cell type-specific expression of rat prolactin and growth hormone genes. Nature (1986) 1.62
Phylogenetic placement of rickettsiae from the ticks Amblyomma americanum and Ixodes scapularis. J Clin Microbiol (1998) 1.62
A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev (1989) 1.62
Reinfection with the agent of human granulocytic ehrlichiosis. Ann Intern Med (1998) 1.60
Human monocytic and granulocytic ehrlichioses. Discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist. Arch Pathol Lab Med (1997) 1.58
Cellular and molecular interrelationships between ticks and prokaryotic tick-borne pathogens. Annu Rev Entomol (1995) 1.55
Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am J Trop Med Hyg (2000) 1.55
Evaluation of the benefits of gastric tube feeding in an elderly population. Arch Fam Med (1993) 1.54
Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin Infect Dis (1998) 1.54
Ehrlichia equi infection of horses from Minnesota and Wisconsin: detection of seroconversion and acute disease investigation. J Vet Intern Med (2000) 1.54
Quantitative real-time PCR for detection of members of the Ehrlichia phagocytophila genogroup in host animals and Ixodes ricinus ticks. J Clin Microbiol (1999) 1.53
Nonlinearity in genetic decoding: homologous DNA replicase genes use alternatives of transcriptional slippage or translational frameshifting. Proc Natl Acad Sci U S A (2000) 1.53
Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in response to temperature. J Clin Microbiol (1999) 1.49
Two regulators of Ste12p inhibit pheromone-responsive transcription by separate mechanisms. Mol Cell Biol (2000) 1.49
Granulocytic Ehrlichiae in Ixodes persulcatus ticks from an area in China where Lyme disease is endemic. J Clin Microbiol (2000) 1.49
A cysteine-rich domain defined by a novel exon in a slo variant in rat adrenal chromaffin cells and PC12 cells. J Biol Chem (1997) 1.48
Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci. Infect Immun (1991) 1.47
Abnormal plasma neuroactive progestagen derivatives in ill, neonatal foals presented to the neonatal intensive care unit. Equine Vet J (2013) 1.47
Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J Clin Microbiol (1999) 1.45
Clinical, laboratory, and epidemiologic features of murine typhus in 97 Texas children. Arch Pediatr Adolesc Med (2001) 1.45
Identification of Ehrlichia chaffeensis by nested PCR in ticks from Southern China. J Clin Microbiol (2000) 1.44
Use of a gonadotrophin-releasing hormone vaccine in headshaking horses. Vet Rec (2010) 1.44
Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J Infect Dis (2000) 1.43
Measurement of plasma colloid osmotic pressure in normal thoroughbred neonatal foals. J Vet Intern Med (2001) 1.43
Antibodies to multiple tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in white-footed mice. J Wildl Dis (1997) 1.43
Isolation of a spotted fever group Rickettsia, Rickettsia peacockii, in a Rocky Mountain wood tick, Dermacentor andersoni, cell line. Appl Environ Microbiol (2001) 1.42